There is concern that COVID‐19 vaccination may adversely affect immune
thrombocytopenia (ITP) patients. Fifty‐two consecutive chronic ITP patients were …

Immune thrombocytopenia (ITP) is an acquired autoimmune disorder that is characterized
by low platelet count and increased bleeding risk. COVID-19 vaccination has been …

Abstract Background Coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 has emerged as a deadliest global pandemic after its …

Cases of de novo immune thrombocytopenia (ITP), including a fatality, following SARS-CoV-
2 vaccination in previously healthy recipients led to studying its impact in preexisting ITP. In …

With the recent outbreak of the COVID-19 pandemic and emergency use authorization of
anti-SARS-CoV-2 vaccines, reports of post-vaccine immune thrombocytopenia (ITP) have …

Summary The coronavirus disease 2019 (Covid‐19) pandemic has had devastating effects
on public health worldwide, but the deployment of vaccines for Covid‐19 protection has …

Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-
2 infection, but to our knowledge, there have been no reports on the association of the …

Abstract Two of them, Pfizer-BioNTech and Moderna contain the mRNA from the virus that
provides our cells instructions for making the SARS-CoV-2 spike proteins. The control blood …

The rollout of the SARS-CoV-2 vaccine is underway, and millions have already been
vaccinated. At least 25 reports of “immune thrombocytopenia”(ITP) or “thrombocytopenia” …

We report 5 cases of prothrombotic immune thrombocytopenia after exposure to the
ChAdOx1 vaccine (AZD1222, Vaxzevria) against severe acute respiratory syndrome …